Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses
Karin Loré(Karolinska University Hospital), Richard A. Koup(Aaron Diamond AIDS Research Center), Soorena Khojasteh(National Institutes of Health), Stephen P. Perfetto(National Institutes of Health), Robert A. Seder(National Institutes of Health), Janaki Kuruppu(National Institute of Allergy and Infectious Diseases), Jason M. Brenchley(National Institutes of Health), Mario Roederer(National Institutes of Health), Michael R. Betts(University of Pennsylvania)
Cited by 290
Related Papers
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k